, Singapore
258 views
(L-R) Juliana Lim, Executive Director - Talent, SGInnovate; Pauline Tay, Director, NHIC; Lim Jui, CEO, SGInnovate; Walter Goh, Director of Discovery, Carcell Biopharma / Investment Team, EVX Ventures DPM Heng Swee Keat; Annie Lim, VP, Human Resources, Hummingbird Bioscience; Yong Ying-I, Chairman, SGInnovate; Serene Tan, CFO, Hilleman Laboratories; Koon Kiat Teu, VP and GM, Singapore, Allay Therapeutics; Chan Lai Fung, Permanent Secretary (National Research and Development) [Photo from SGInnovate]

SGInnovate rolls out talent strategy for tech sector 

The strategy has three focus areas.

Government-backed deep tech ecosystem builder, SGInnovate, has launched an integrated strategy for solving talent challenges across emerging tech sectors, the Deep Tech Talent Central (DTTC).

The strategy focuses on three areas: 

  • Building communities of practice through domain-specific, open-access sharings with experts and industry leaders;
  • Helping individuals deepen skillsets by curating training programmes with public and private sector partners to address specific areas of need; and
  • Responding to evolving talent gaps and providing platforms for practical learning and experience for talent with technical skill sets.

SGInnovate said the DTTC will “streamline the way organisations and talent come together to resolve demand- and supply-side issues.”

To do so, SGInnovate said it will work with partners to identify resources and coordinate and curate training and development initiatives from across the ecosystem for deep tech talent at all levels.

“This approach offers individuals with an interest in emerging technologies support across all stages of career development – ranging from activities which help build early awareness and fuel discovery, through to career expansion programmes for those already pursuing a Deep Tech career,” SGInnovate said.

Through the DTTC, SGInnovate expects to catalyse more than 10,000 connections between talent and its partner companies each year.

Meanwhile, SGInnovate also launched an industry training programme for academic and research professionals in the biotech sector called the “Helix Immersion Programme," with the aim to support the growing number of biomedical and biotech companies in Singapore as they scale. 

The one-year on-the-job-training programme will enable biomedical research and academic professionals to gain industry experience across the lab and non-lab-based roles at fast-growing companies in this space.

SGInnovate expects to train more than 100 HIP fellows by 2025.

In its inaugural run, the HIP will have five partner companies who will offer training positions in the following areas: Chemistry and Manufacturing Controls (CMC), Drug Metabolism and Pharmacokinetics (DMPK) or Absorption, Drug Metabolism, Excretion and Toxicology (ADMET), regulatory affairs, and pharma-level project management.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.